ak 295 has been researched along with egtazic acid in 1 studies
*Egtazic Acid: A chelating agent relatively more specific for calcium and less toxic than EDETIC ACID. [MeSH]
*Egtazic Acid: A chelating agent relatively more specific for calcium and less toxic than EDETIC ACID. [MeSH]
| Studies (ak 295) | Trials (ak 295) | Recent Studies (post-2010) (ak 295) | Studies (egtazic acid) | Trials (egtazic acid) | Recent Studies (post-2010) (egtazic acid) |
|---|---|---|---|---|---|
| 13 | 0 | 0 | 10,021 | 11 | 686 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Culver, DG; Glass, JD; Wang, MS; Wu, Y | 1 |
1 other study(ies) available for ak 295 and egtazic acid
| Article | Year |
|---|---|
Pathogenesis of axonal degeneration: parallels between Wallerian degeneration and vincristine neuropathy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Axons; Axotomy; Calpain; Cells, Cultured; Chelating Agents; Cysteine Proteinase Inhibitors; Dipeptides; Egtazic Acid; Female; Ganglia, Spinal; Pregnancy; Rats; Rats, Sprague-Dawley; Vincristine; Wallerian Degeneration | 2000 |